Truxene被用作成功合成新型共价有机骨架(COF)的基础。戊烯(10,15-二氢-5 H-二茚并[1,2- a:1',2'- c ]芴,TX)与1,4-苯二硼酸(DBA)之间的缩合反应导致结晶COF具有硼酸酯键(COF-TXDBA)且表面积为1526 m 2 g -1如粉末X射线衍射(PXRD)和Brunauer-Emmett-Teller(BET)表面积测量所证实。这是第一项研究,其中显示了由周期性COF平面层生成的纳米通道可减轻硼酸酯键与水分子之间的相互作用,从而实现有效的湿度感测。基于COF-TXDBA的%RH传感器在11–98%RH范围内阻抗变化了3个数量级,响应时间和恢复时间分别为37 s和42 s。通过在%RH范围的4个回路中来回切换COF-TXDBA传感器而测得的响应瞬变显示出传感器的出色可逆性,在切换过程中的偏差为2.3%。
A novel one-pot thermal cycloaddition of two indenones followed by a decarbonylation and dehydrogenation cascade afforded benzo[c]fluorenones regioselectively. Various substituted indenone derivatives were converted into their corresponding benzo[c]fluorenones in good to excellent yields.
新颖的一锅法将两个茚满进行热环加成,然后进行脱羰和脱氢级联反应,从而选择性地提供了苯并[ c ]芴酮。各种取代的茚满酮衍生物均以良好或优异的产率转化为相应的苯并[ c ]芴酮。
FACILE SYNTHESIS OF INDENONES FROM INDANONES: A NEW PROCEDURE
作者:Frank M. Hauser、Maotang Zhou、Yuanqiang Sun
DOI:10.1081/scc-100000182
日期:2001.1
A two-step procedure for the conversion of indanones to indenones is described.
Tricyclic indeno-pyrrole derivatives as serotonin receptor modulators
申请人:Bennani L. Youssef
公开号:US20060025601A1
公开(公告)日:2006-02-02
The present invention generally relates to a series of compounds, to pharmaceutical compositions containing the compounds, and to use of the compounds and compositions as therapeutic agents. More specifically, compounds of the present invention are tricyclic indeno-pyrrole compounds. These compounds are serotonin receptor (5-HT) ligands and are useful for treating diseases, disorders, and conditions wherein modulation of the activity of serotonin receptors (5-HT) is desired (e.g. anxiety, depression and obesity).
TRICYCLIC INDENO-PYRROLE DERIVATIVES AS SEROTONIN RECEPTOR MODULATORS
申请人:Bennani Youssef L.
公开号:US20090239925A1
公开(公告)日:2009-09-24
The present invention generally relates to a series of compounds, to pharmaceutical compositions containing the compounds, and to use of the compounds and compositions as therapeutic agents. More specifically, compounds of the present invention are tricyclic indeno-pyrrole compounds. These compounds are serotonin receptor (5-HT) ligands and are useful for treating diseases, disorders, and conditions wherein modulation of the activity of serotonin receptors (5-HT) is desired (e.g. anxiety, depression and obesity).
Di- and tri-heteroatom substituted indenyl metal complexes
申请人:The Dow Chemical Company
公开号:US06555634B1
公开(公告)日:2003-04-29
Novel metal complexes containing at least two heteroatoms attached to an indenyl or substituted indenyl radical which is bridged by ligand group thereby forming a covalent or coordinate/covalent bond to the metal, the use of such metal complexes in the formation of polymerization catalysts and processes for polymerizing &agr;-olefins using such catalysts.